Antiviral Drugs for Cirrhosis and Hepatitis

Viruses are the intracellular parasites that depend on synthetic processes of host cells. They cannot be grown on ordinary medium. Special microscopes are needed to visualize their structure, which consists of Genome (genetic material consisting of DNA or RNA component but never both), Surrounding capsid –proteinaceous in structure, Envelope –protein bilayer. Hepatitis B virus (HBV) is an important cause of end-stage liver disease and hepatocellular carcinoma (HCC). The decision to treat is based on the activity of liver disease and HBV replication status, and the likelihood of a long-term benefit. Approved therapies include standard and pegylated interferon-alfa and nucleoside analogues: lamivudine, adefovir and entecavir. Even with successful therapy, patients remain at risk for reactivation of viral replication and require lifelong monitoring.

HBV in HBsAg-positive patients treated with allogeneic hematopoietic cell transplantation. Highly active antiretroviral therapy is initiated for decreasing mortality relating to HIV. Influenza can be type A, B or C depending upon type. Influenza A and B are more common.

  • Anti-retroviral agents
  • Antiviral Regimens
  • Anti-herpes virus agents
  • Anti influenza agents

Related Conference of Antiviral Drugs for Cirrhosis and Hepatitis

December 02-03, 2021

4th World Liver Congress

Amsterdam, Netherlands
February 21-22, 2022

17th Euro-Global Gastroenterology Conference

Berlin, Germany
April 25-26, 2022

International Conference on Hepatitis & Liver diseases

Sydney, Australia
May 12-13, 2022

Summit on Pancreas, Gastroenterology and Digestive Diseases

Amsterdam, Netherlands
June 13-14, 2022

28th World Conference on Gastroenterology & Hepatology

Amsterdam, Netherlands
July 18-19, 2022

International Conference on Gastroenterology and Liver

Amsterdam, Netherlands
July 20-21, 2022

21th World Gastroenterologists Summit

Osaka, Japan
July 20-21, 2022

Digestive disorders 2022

Amsterdam, Netherlands
August 03-04, 2022

31st World Congress on Nursing

Rome, Italy
November 14-15, 2022

13th International Conference on Liver Diseases & Hepatology

Amsterdam, Netherlands

Antiviral Drugs for Cirrhosis and Hepatitis Conference Speakers

Recommended Sessions

Related Journals

Are you interested in